85 related articles for article (PubMed ID: 17563602)
1. The effects of copayments on medication adherence during the first two years of prescription drug treatment.
Kessler RC; Cantrell CR; Berglund P; Sokol MC
J Occup Environ Med; 2007 Jun; 49(6):597-609. PubMed ID: 17563602
[TBL] [Abstract][Full Text] [Related]
2. Consumer response to dual incentives under multitiered prescription drug formularies.
Gilman BH; Kautter J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
[TBL] [Abstract][Full Text] [Related]
3. The effects of prescription drug copayments on statin adherence.
Gibson TB; Mark TL; McGuigan KA; Axelsen K; Wang S
Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
[TBL] [Abstract][Full Text] [Related]
4. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
5. Effect of a medication copayment increase in veterans with schizophrenia.
Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
[TBL] [Abstract][Full Text] [Related]
6. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
Cole JA; Norman H; Weatherby LB; Walker AM
Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
[TBL] [Abstract][Full Text] [Related]
7. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
Taira DA; Wong KS; Frech-Tamas F; Chung RS
Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
[TBL] [Abstract][Full Text] [Related]
8. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
[TBL] [Abstract][Full Text] [Related]
9. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
10. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs.
Stroupe KT; Smith BM; Lee TA; Tarlov E; Durazo-Arvizu R; Huo Z; Barnett T; Cao L; Burk M; Cunningham F; Hynes DM; Weiss KB
Med Care; 2007 Nov; 45(11):1090-7. PubMed ID: 18049350
[TBL] [Abstract][Full Text] [Related]
11. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
[No Abstract] [Full Text] [Related]
12. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
[TBL] [Abstract][Full Text] [Related]
13. The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization.
Colombi AM; Yu-Isenberg K; Priest J
J Occup Environ Med; 2008 May; 50(5):535-41. PubMed ID: 18469622
[TBL] [Abstract][Full Text] [Related]
14. Associations between prescription copayment levels and β-blocker medication adherence in commercially insured heart failure patients 50 years and older.
Patterson ME; Blalock SJ; Smith AJ; Murray MD
Clin Ther; 2011 May; 33(5):608-16. PubMed ID: 21665045
[TBL] [Abstract][Full Text] [Related]
15. Incentive formularies and changes in prescription drug spending.
Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
[TBL] [Abstract][Full Text] [Related]
16. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
17. Impact of decreasing copayments on medication adherence within a disease management environment.
Chernew ME; Shah MR; Wegh A; Rosenberg SN; Juster IA; Rosen AB; Sokol MC; Yu-Isenberg K; Fendrick AM
Health Aff (Millwood); 2008; 27(1):103-12. PubMed ID: 18180484
[TBL] [Abstract][Full Text] [Related]
18. Effect of tiered prescription copayments on the use of preferred brand medications.
Rector TS; Finch MD; Danzon PM; Pauly MV; Manda BS
Med Care; 2003 Mar; 41(3):398-406. PubMed ID: 12618643
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease.
Nair KV; Wolfe P; Valuck RJ; McCollum MM; Ganther JM; Lewis SJ
J Manag Care Pharm; 2003; 9(2):123-33. PubMed ID: 14613341
[TBL] [Abstract][Full Text] [Related]
20. Copayments for medications in 2012. Final rule.
Department of Veterans Affairs
Fed Regist; 2012 May; 77(93):28258-9. PubMed ID: 22606731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
